EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment

Yi Feng, Haoxin Yang, Guicai Liang, Jun Chen, Tao Li, Yingjuan Wang, Jilin Chang, Yan Li, Meng Yang, Xilong Zhou, Zhiqiang Wang, Chunlei Ge

Oncology Research · 2025

DOI: 10.32604/or.2025.067824 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Research, 2025. Verfasst von Yi Feng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer…. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirotherapyImmune Checkpoint InhibitorsNeoplasmsHumansCombined Modality TherapyTumor MicroenvironmentOncolytic VirusesImmunotherapyAnimals

Stichwörter der Autor:innen

Immune checkpoint inhibitors (ICIs)cancer immunotherapyoncolytic virotherapy (OV)tumor microenvironment (TME)

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cancer Biotherapy Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
  • Department of Laboratory Animal Science, Kunming Medical University, Kunming, 650500, China.
  • Department of Neurosurgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
  • Department of Radiology, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, 650118, China.
  • Department of Radiation Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.

Zitieren

APA

Feng, Y., Yang, H., Liang, G., Chen, J., Li, T., Wang, Y., Chang, J., Li, Y., Yang, M., Zhou, X., Wang, Z., & Ge, C. (2025). Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. Oncology Research. https://doi.org/10.32604/or.2025.067824

Vancouver

Feng Y, Yang H, Liang G, Chen J, Li T, Wang Y, et al. Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment. Oncology Research. 2025. doi:10.32604/or.2025.067824

BibTeX
@article{Feng2025,
  author = {Feng, Yi and Yang, Haoxin and Liang, Guicai and Chen, Jun and Li, Tao and Wang, Yingjuan and Chang, Jilin and Li, Yan and Yang, Meng and Zhou, Xilong and Wang, Zhiqiang and Ge, Chunlei},
  title = {Immune Checkpoint Inhibitors Combined with Oncolytic Virotherapy: Synergy, Heterogeneity, and Safety in Cancer Treatment},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.067824}
}
Kostenlos starten →